Veru Inc. (VERU) Fundamentals

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.
SHARE INFORMATION
Market Cap$ 1,144,252,930
Shares Outstanding80,073,683
Float64,475,027
Percent Float80.52%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 61,259,528
Latest Fiscal EPS$ 0.11
Latest Fiscal Date2021-09-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions253
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months2,155,385
Institutional Holdings Percent63.7%
Institutional Sold Previous 3 Months5,371,307
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months5,000
Insider Holdings Percent19.4
Insider Sold Previous 3 Months-
Insider Shares Owned15,527,140
TRADING INFO
52 Week High$ 17.50
52 Week Low$ 4.34
52 Week High Change$ 77.96
21 Day Moving Average$ 11.3462
21 Day Extended Moving Average$ 11.327
50 Day Moving Average$ 8.7184
50 Day Extended Moving Average$ 9.5608
200 Day Moving Average$ 7.5735
200 Day Extended Moving Average$ 7.828
10 Day Average Volume31,294,229
20 Day Average Volume24,785,844
30 Day Average Volume46,491,319
50 Day Average Volume28,169,023
Alpha0.088204
Beta-0.5774
Standard Deviation0.358391
R20.005816
7 Day Price Change$ 5.26
7 Day Percent Change58.25%
21 Day Price Change$ 2.22
21 Day Percent Change18.39%
30 Day Price Change$ 1.65
30 Day Percent Change13.05%
Month to Date Price Change$ 2.57
Month to Date Percent Change21.93%
Quarter to Date Price Change$ 9.46
Quarter to Date Percent Change195.86%
180 Day Price Change$ 6.46
180 Day Percent Change82.5%
200 Day Price Change$ 6.12
200 Day Percent Change74.91%
Year to Date Price Change$ 8.40
Year to Date Percent Change142.61%

Veru Inc. (VERU) Key Ratios

PROFITABILITY
EBIT Margin-42.8%
EBITDA Margin-42.5%
Pre-Tax Profit Margin-57.5%
Profit Margin Count-45.11%
Gross Margin81.4%
Profit Margin TOT-45.11%
INCOME STATEMENTS
Revenue$ 60,465,578
Revenue Per Share$ 0.7551
Revenue (3 Years)$ 30.07
Revenue (5 Years)$ 37.88
FINANCIAL STRENGTH
Price to Tangible Book9.60
Total Debt To Equity0.20
Int Coverage-5.40
Current Ratio6.60
Leverage Ratio1.20
Quick Ratio5.80
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio-44.10
Enterprise Value$ 1,110,128,900
Price to Sales18.924
Price to Free Cash-48.90
PE High Last 5 Years267.70
Price To Book8.80
Price To Cash Flow528.30
PE Low Last 5 Years-10.30
Price to Tangible Book9.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.60
Invoice Turnover1.60
Assets Turnover0.50
Return Assets-16.02
Return on Equity-19.48
Return on Capital-14.24

Veru Inc. (VERU) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorRSM US LLP
CEOMitchell S. Steiner
Emplyoees252
Last AuditUQ
CIK0000863894
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Nanotechnology(541713)
CONTACT INFO
Address48 NW 25th Street
Suite 102
Miami, FL 33137
Websitehttps://www.verupharma.com
Facsimile-
Telephone+1 305 509-6897
Emailveruinvestor@verupharma.com
Your Recent History
NASDAQ
VERU
Veru
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220522 04:48:29